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Yoshio Takagaki,* Rebecca L. Seipelt,† by Peterson, 1994a). These observations indicate that
the balance between mm splicing and polyadenylationMartha L. Peterson,† and James L. Manley*
versus polyadenylation at the ms site determines the*Department of Biological Sciences
mode of RNA processing and suggest that regulationColumbia University
may be exerted by factors that influence splicing orNew York, New York 10027
polyadenylation or both. In an extension of these find-†Department of Pathology and Laboratory Medicine
ings, an artificial pre-mRNA containing the same ar-Department of Microbiology and Immunology
rangement of splicing and polyadenylation signals asUniversity of Kentucky Medical Center
the m gene, but derived from heterologous genes, isLexington, Kentucky 40536
regulated appropriately (Peterson, 1994b), indicating
that gene-specific factors are unnecessary for regula-
tion. Furthermore, several experiments have suggestedSummary
that an increase in 39-end cleavage/polyadenylation effi-
ciency plays an important role in the switch from mm toThe switch from membrane-bound to secreted-form
ms mRNA (Peterson et al., 1991; reviewed by Peterson,IgM that occurs during differentiation of B lympho-
1994a). These findings suggest thepossible involvement
cytes has long been known to involve regulated pro-
of a component of the basal polyadenylation machinery
cessing of the heavy chain pre-mRNA. Here, we show in m gene regulation.
that accumulation of one subunit of an essential poly- The factors required for pre-mRNA polyadenylation
adenylation factor (CstF-64) is specifically repressed in higher eukaryotes have been well studied and consist
in mouse primary B cells and that overexpression of of a large and complex set of proteins (reviewed by
CstF-64 is sufficient to switch heavy chain expression Keller, 1995; Manley, 1995). Cleavage-polyadenylation
from membrane-bound (mm) to secreted form (ms). We specificity factor (CPSF) consists of 3–4 subunits and
further show that CstF-64 is limiting for formation of recognizes the polyadenylation signal AAUAAA via its
intact CstF, that CstF has a higher affinity for the mm 160 kDa subunit (e.g., Jenny et al., 1994; Murthy and
poly(A) site than for the ms site, and that the mm site Manley, 1995). Cleavage stimulation factor (CstF; Taka-
is stronger in a reconstituted in vitro processing reac- gaki et al., 1989) contacts variable downstream GU-rich
tion. Our results indicate that CstF-64 plays a key role sequences that influence the efficiency of polyadenyla-
in regulating IgM heavy chain expression during B cell tion (reviewed by Proudfoot, 1991). CPSF and CstF co-
differentiation. operate to form a stable complex on thepre-mRNA (e.g.,
Gilmartin and Nevins, 1991; Murthy and Manley, 1992)
and are thus capable of specifying thesite of polyadenyl-Introduction
ation. At least three other factors, cleavage factors I and
II and poly(A) polymerase, join the complex to initiateGene expression can be controlled in multiple ways, one
the polyadenylation reaction.of which is alternative pre-mRNA processing. A classical
CstF is composed of subunits of 77, 64, and 50 kDaexample of this mechanism is the regulation of immuno-
(Takagaki et al., 1990). CstF-77 functions as a bridgeglobulin M heavy chain (IgM H-chain) synthesis during
between the other two CstF subunits, CstF-50 and -64B cell differentiation. Pre-B and B cells produce large
(Takagaki and Manley, 1994) and also interacts specifi-amounts of mRNA encoding the membrane-bound form
cally with CPSF (Murthy and Manley, 1995). CstF-50of IgM H-chain (mm), while differentiated plasma cells
contains seven WD-40 repeats (Takagaki and Manley,synthesize primarily mRNA encoding the secreted form
1992) and is essential for CstF activity (Takagaki and(ms). This switch involves use of a downstream mm-
Manley, 1994), but its function is unknown. CstF-64,
specific polyadenylation site in B cells and an upstream
which directly contacts the GU-rich region of the pre-
ms-specific poly(A) site in plasma cells (Alt et al., 1980;
mRNA (e.g., MacDonald et al., 1994), contains an
Rogers et al., 1980; Early et al., 1980). However, the N-terminal ribonucleoprotein-type RNA-binding domain
change in processing is complex in that usage of the (RBD) and unusual C-terminal domains of unknown
mm poly(A) site is associated with an upstream splicing function (Takagaki et al., 1992; see below). Several ob-
event that removes the ms poly(A) site (see Figure 1A). servations are consistent with a role for CstF in regula-
This complexity has led to models involving control of tion. As mentioned above, CstF participates in the earli-
splicing, polyadenylation, and even transcription termi- est stage of poly(A) site specification by binding a
nation as the regulatory mechanism (for reviews see variable efficiency element. CstF-77 is the homolog of
Guise et al., 1989; Peterson, 1994a). a Drosophila protein encoded by a classical modifier
Previous transfection experiments using wild-type gene, suppressor of forked [su(f)] (Mitchelson et al.,
and mutant m gene constructs have identified several 1993; Takagaki and Manley, 1994). Mutations in su(f)
cis-acting elements that can affect regulated pro- modify mutant phenotypes of unlinked genes, appar-
cessing. These include the distance between the ms ently by changing the relative utilization of alternative
poly(A) site and the downstream mm exons and poly(A) poly(A) sites (reviewed by O’Hare, 1995). CstF activity
site, the strength of the mm poly(A) site relative to the has also been reported to vary during adenovirus infec-
ms site, the suboptimal sequence of the mm-associated tion of HeLa cells (Mann et al., 1993). Furthermore, muta-
tions in RNA 14 and RNA 15, which encode the putative59 splice site, and the size of the Cm4 exon (reviewed
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yeast homologs of CstF-77 and -64 (Takagaki and Man-
ley, 1994), can alter poly(A) site use in that organism
(Mandart and Parker, 1995).
In this study, we have investigated the roles of trans-
acting factors in m gene regulation. We show that CstF-
64 is specifically up-regulated during B cell differentia-
tion. Overexpression of CstF-64 in a B cell line increases
the concentration of intact CstF and reproduces the
shift in IgM pre-mRNA processing that naturally occurs
during differentiation. We also provide evidence that the
mechanism by which changes in CstF concentration
modulate poly(A) site selection involves different affini-
ties of CstF for the mm and ms poly(A) sites.
Results
Accumulation of CstF-64 Is Regulated
during Differentiation of Primary B Cells
To test the possibility that regulation of m gene expres-
sion during B cell differentiation involves changes in
known polyadenylation or splicing factors or both, we
first isolated primary B cells from mouse spleen and
induced them to differentiate with lipopolysaccharide
(LPS). The levels of several RNA processing factors in
lysates of the resting and induced cells were then mea-
sured by Western blotting (Figure 1B). Accumulation of
CstF-77 was virtually identical in the resting and induced
cells (lanes 2 and 3), and these levels were similar to
those found in other cell types (e.g., HeLa, lane 1). In
contrast, striking differences in accumulation of CstF-
64 in the two cell types were detected (results from two Figure 1. Expression of the m Gene and of Splicing and Polyadenyla-
preparations of B cells [a and b] areshown). Quantitation tion Factors during B Lymphocyte Differentiation
indicated 10–20-fold increases in CstF-64 accumulation (A) m gene expression is regulated by alternative RNA processing.
The exons encoding leader (L), variable (V), diversity (D), junctionduring differentiation. This reflects very low levels of the
(J), and constant regions (Cm1–Cm4) are shared by both mm and msprotein in resting B cells (lanes 5 and 7), which were
mRNAs, while exons M1 and 2 and S are specific to mm and msincreased in activated cells (lanes 6 and 8) to approach
mRNAs.
the levels in HeLa cells (lane 4). The species indicated (B) Expression of CstF-64 is specifically reduced in mouse primary
by asterisks correspond to Ig H- and L- chains, which B cells. Whole-cell lysates (18 mg each) prepared from HeLa cells
were detected by thesecondary antibody used to visual- (HeLa, lanes 1, 4, and 9), mouse resting B cells (LPS2, lanes 2, 5,
7, and 10), and LPS-activated B cells (LPS1, lanes 3, 6, 8, and 11)ize the anti-64K antibody. The increases in H-chain ex-
were analyzed by Western blotting with an anti-CstF77 antibodypression in the LPS-stimulated cells confirm the effec-
(lanes 1–3), with an anti-CstF64 (lanes 4–8), orwith an anti-SR proteintiveness of the induction procedure, which is also
antibody (lanes 9–11). Endogenous mouse Ig H- and L-chains (aster-
indicated by the observation that the ms/mm mRNA ratio isks) were also detected by the anti-mouse IgG antibody in the B
increased at least 7-fold following LPS stimulation (data cell lysates.
not shown). We also examined accumulation of mem-
bers of the SR protein family of splicing factors, using cells might be sufficient to induce the mm-to-ms mRNA
an antibody that recognizes all known SR proteins (Roth processing switch. Our strategy was to establish B cell
et al., 1990). The results (lanes 10 and 11; data not lines overexpressing CstF-64 and then to examine the
shown) indicate at most slight changes in the levels of
pattern of m gene expression in overexpressing and con-
any of these proteins following LPS induction. Together,
trol cells. We chose for this the chicken B cell line DT40
our data indicate that accumulation of CstF-64 is signifi-
(Buerstedde et al., 1990), for several reasons. First, the
cantly and specifically reduced in resting B cells but is
ms-to-mm ratio mRNA is relatively low (approximately 1;
increased substantially during differentiation. The en-
see below), approaching the ratio found in natural B
hanced accumulation of CstF-64 observed following in-
cells. Second, DT40 cells are transfected efficiently and
duction of B cells is not a common response seen when
grow rapidly (Buerstedde and Takeda, 1991). Third,
any resting cells are stimulated to divide, since CstF-
should we be successful in showing that enhanced
64 levels in normal (nonproliferating) and CCl4-treated CstF-64 expression can regulate m gene expression in
(proliferating) liver cells remained constant (data not DT40 cells, the results would suggest that this mecha-
shown). nism of control is conserved throughout vertebrates.
Finally, to ensure that any results we might obtain did
not reflect possiblespecies-specific differences, we iso-Structure of Chicken CstF-64
We next wished to investigate whether the increase in lated chicken (c) CstF-64 cDNAs. This allowed a phylo-
genetic comparison of CstF-64 sequences from severalCstF-64 observed during induction of mouse primary B
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Chicken CstF-64 isnearly 100% identical to the mamma-
lian proteins in the RBD and hinge domains, suggesting
that important protein–RNA and protein–protein interac-
tions are conserved. Although the remainder of the pro-
tein also displays a high degree of similarity, there are
two notable differences. First, changes in the first 200
residues of the pro 1 gly–rich region (up to the repeat
domain) increase the pro 1 gly content to a striking
45%. Second, the number of repeats is reduced from
12 to 11, and the identity of the third position is changed
from ala to pro in 7 of the11 repeats, which could disrupt
the a-helical structure of the repeat domain. Although
the significance of these changes is unknown, this com-
parison suggests that there could be species-specific
differences in CstF-64 function between mammals and
chicken, and the chicken cDNA was therefore used in
the transformation experiments described below.
Overexpression of CstF-64 in DT40 Cells Switches
m Gene Expression from Membrane-Bound
to Secreted Form
To determine whether enhanced expression of CstF-
64 could alter m gene pre-mRNA processing, we first
isolated DT40 clones stably transformed with a vector
capable of expressing cCstF-64. The vector (pApuro-
flu64K or flu64K; Figure 3A) encodes a CstF-64 deriva-
tive containing an N-terminal flu-epitope and provides
puromycin resistance as a selectable marker. As an ini-
tial control, clones from cells transformed with the pa-
Figure 2. Protein Domain Features of Chicken, Mouse, and Human rental vector lacking a cDNA insert were also isolated.
CstF-64 Figure 3B presents a Western blot of cell lysates from
(A) CstF-64 is divided into seven structural domains (Takagaki et al. clones arising from flu64K-transformed cells, using an
1992), the N-terminus (N, amino acid residues 1–16), a ribonucleo- anti-flu monoclonal antibody. The results show that
protein-type RNA-binding domain (RBD, 17–96), hinge domain most of the clones expressed similar amounts of flu
(Hinge, 97–197), Pro/Gly–rich regions (Pro/Gly, 198–405 and 461–
CstF-64, although one, number 34, expressed extremely522), the repeat structure (Repeat, 406–460), and C-terminus (C,
high levels. While these findings confirm that it is possi-523–573). The amino acid sequence of the chicken (top) and mouse
ble to obtain clones expressing exogenous CstF-64, for(bottom; Y.T. and J. L. M., unpublished data) proteins are compared
with human CstF-64 (center; Takagaki et al., 1992), and amino acid our experiments it was important to determine the total
identities in each domain are shown. amount of CstF-64 in the transformed cells. We therefore
(B) Comparison of the repeat structures of chicken (left) and human carried out Western blots of cell lysates from untrans-
(right) CstF-64. Amino acid residues are presented so that the penta-
formed, vector-transformed, and flu64K-transformedpeptide repeating units are aligned from the top downwards, and
cells, using anti–CstF-64 antibodies. Preliminary resultsthe first and last residues are numbered. Consensus sequences are
(data not shown) found no differences between mock-shown at the bottom.
and vector-transformed cells. We therefore chose sev-
eral vector- and flu64K-transformed cell lines for further
analysis and present results obtained with two of eachspecies, which produced insights into potentially impor-
tant protein domains. type. Figure 3C displays the results of Western analysis
using the anti–CstF-64 antibodies with lysates of theThe sequence of human (h) CstF-64 suggests several
interesting features (Takagaki et al., 1992; Figure 2A). vector- and flu64K-transformed cell lines. To rule out
the possibility that any differences inCstF-64 levels wereFollowing the N-terminal RBD, the protein contains a
“hinge” region that is responsible for interactions with due to variations in cell growth, we analyzed samples
isolated at several cell densities, two of which areother polyadenylation factors (Y. T. and J. L. M., unpub-
lished data). The hinge region is followed by a long shown. Quantitation of CstF-64 levels revealed that the
two flu64K-transformed cell lines contained approxi-(approximately 300 residues) region that is approxi-
mately 40% pro 1 gly. However, within this region is mately 10-fold more CstF-64 than did the control cells
and that this difference was independent of cell density.a 60 residue domain consisting of 12 repeats of the
pentapeptide MEARA/G. In contrast to the apparently This increase in CstF-64 concentration roughly repro-
duces the change observed when mouse primary B cellslargely unstructured region surrounding it, this domain
forms a long stable a helix (Y. T., M. Nomizu, and J. L. M., were induced with LPS.
To determine whether enhanced CstF-64 accumula-unpublished data). Figure 2A presents a comparison of
human, mouse, and chicken CstF-64 sequence features tion affected m mRNA processing, we examined the lev-
els of ms and mm mRNA in vector- and flu64K-trans-and amino acid identities. The mouse and human pro-
teins are highly homologous over their entire length. formed cells by nuclease S1 mapping. Total cell RNA
Cell
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Figure 3. Overexpression of CstF-64 in
Chicken DT40 Cells
(A) Structure of expression vector encoding
chicken 64K. A DNA fragment encoding flu
epitope-tagged cCstF-64 was inserted into
the pApuro vector (top) downstream of the
chicken b-actin promoter. Expression of the
puromycin-resistance gene (puror) is driven
by the SV40 early promoter, and the Moloney
murine leukemia virus long terminal repeat
provides the poly(A) site.
(B) Expression of exogenous CstF-64. Whole-
cell lysates (18 mg) derived from parental
DT40 cells (lane 1), pApuro vector (lanes 2
and 3), and pApuro-flu64K (lanes 4–11)–
transformed cells were analyzed by Western
blotting using an anti-flu epitope antibody.
Cell lines are numbered on top, and the posi-
tion of flu-tagged cCstF-64 is indicated by an
arrowhead on the right.
(C) Expression of total CstF-64. Whole-cell
lysates (25 mg) derived from two independent
pApuro vector (numbers 6 and 7, lanes 1–4)
and pApuro-flu64K–transfected cell lines
(numbers 23 and 24, lanes 5–8), harvested
early (a, lanes 1, 3, 5, and 7) or late (b, lanes
2, 4, 6, and 8) in log phase, were analyzed by
Western blotting using an anti–CstF-64 anti-
body. The position of CstF-64 is indicated by
an arrowhead on the right.
was isolated from the same clones analyzed for CstF- in ms mRNA in number 23 cells and strengthen our con-
clusion that overexpression of CstF-64 in DT40 cells64 levels in Figure 3C, again analyzing samples from
cells at different densities. Results from nuclease S1 switches m gene expression from the membrane-bound
to the secreted form.analysis are shown in Figure 4A, and the ms/mm mRNA
ratios are presented in Figure 4B. The two cell lines
overexpressing CstF-64, numbers 23 and 24, displayed
marked changes in the ms/mm mRNA ratio. The ratio Overexpression of CstF-64 Enhances CstF
Complex Formationwas increased from approximately 1 in parental DT40
cells (data not shown) to approximately 8 in flu64K- We next wished to gain insight into the mechanism by
which elevated concentrations of CstF-64 increase thetransformed cells, while vector-transformed cells dis-
played approximately the same ratio as nontransformed ms/mm mRNA ratio. As a first question, we asked
whether elevated CstF-64 concentrations resulted incells. Cell density had at most minimal effects on the
ratios observed. Analysis of additional flu64K- and vec- higher levels of the heterotrimeric CstF complex. Given
that the levels of CstF-77 remained constant during thetor-transformed clones gave results (data not shown)
similar to those presented. Most notably, number 34 LPS-induced differentiation of mouse B cells (see Figure
1B), it seemed possible that CstF-64 levels were limitingcells, which overproduce CstF-64 by more than 50-fold,
displayed a ms/mm ratio similar to that of number 23 for complex formation in B cells and that increasing the
concentration of CstF-64 increased the amount of intactand number 24 cells. This suggests that at these high
levels of CstF-64, some other factor necessary for pref- CstF. To test this in DT40 cells, we first examined the
levels of CstF-77 in whole-cell lysates of vector (numbererential use of the ms poly(A) site becomes limiting, so
that the ms/mm ratio cannot increase further. As an addi- 6)-and flu64K (number 23)-transformed cells by Western
blotting (Figure 5A). In contrast to CstF-64 levels, thetional control, we analyzed clones expressing a CstF-
64 mutant lacking an RBD. The ms/mm mRNA ratio in amount of CstF-77 was constant in the two cell lines,
and similar results (data not shown) were obtained withthese cells was equivalent to that observed with vector-
transformed cells (data not shown). other transformed cell lines. We next determined the
amount of CstF-77 complexed with CstF-64 in the twoTo verify the increase in ms mRNA synthesis by an
independent method, we quantitated the amounts of cell lines by immunoaffinity chromatography with an
anti–CstF-64 antibody. Purified complexes were ana-IgM H-chain protein in the culture medium of flu64K-
and vector-transformed cells. Number 6 and number 23 lyzed by Western blotting, and the results (Figure 5B)
indicated that approximately 4-fold more CstF-77 wascells were grown at two different cell densities, and
aliquots of the cell culture supernatants were analyzed associated with CstF-64 in extracts of number 23 cells
than in number6 cell extracts. These results indicate thatby Western blot using an anti-chicken IgM H-chain anti-
body (Figure 4C). At both cell densities, number 23 cells CstF-64 is indeed limiting for CstF complex formation in
B cells, and therefore an increase in CstF-64 levels likelysecreted approximately 4-fold more IgM than did num-
ber 6 cells. These values agree well with the increase raises the concentration of functionally active CstF.
Regulation of IgM Pre-mRNA Processing
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Figure 4. Overexpression of CstF-64 Can Switch m Gene Expression from mm to ms
(A) S1 nuclease analysis of IgM H-chain mRNAs. tRNA (lane 2) or total cellular RNA isolated from pApuro vector (lanes 3–6) and pApuro-
flu64K (lanes 7–10)–transfected cell lines was hybridized with a 32P-labeled DNA probe (lane 1), digested with S1 nuclease, and the protected
DNA fragments fractionated on a denaturing polyacrylamide gel. Positions of DNA size markers and the protected DNA fragments corresponding
to the spliced (mm) and polyadenylated (ms) mRNAs are indicated on the left and right, respectively. The probe for S1 nuclease analysis is
diagrammed at the bottom.
(B) ms/mm mRNA ratios. The amounts of ms and mm mRNAs were quantitated from the polyacrylamide gel shown in (A) by Phosphorimager
and the calculated ms/mm mRNA ratios for pApuro- flu64K (numbers 23 and 24, solid lines) and pApuro vector (numbers 6 and 7, dashed
lines)–transfected cell lines are shown.
(C) Expression of IgM H-chain. The pApuro vector (number 6, lanes 1 and 2) and pApuro-flu 64K (number 23, lanes 3 and 4)–transfected cell
lines were grown for 2 days initially at two different cell densities (a 5 2 3 104 cells/ml, b 5 4 3 104 cells/ml). Culture supernants (15 ml) were
analyzed by Western blotting. Position of IgM H-chain is indicated by an arrowhead on the right.
Purified CstF Prefers the mm poly(A) Site GST–RBD formed stable complexes with the mm RNA,
but only a weak interaction was detected with the msHow do changes in CstF concentration result in a shift
from mm to ms pre-mRNA processing? An attractive RNA. The second method also employed gel-shift
assays but with intact CstF purified from HeLa cells.model is that CstF is limiting for poly(A) site complex
formation in B cells and that the site in m pre-mRNA The results (Figure 6B) were very similar to those ob-
tained with GST–RBD: CstF bound the mm RNA with awith the highest affinity for CstF is at a competitive
advantage. Given that the mm site is used most effi- significantly higher affinity (approximately 5-fold) than
that with which it bound the ms RNA.ciently in B cells, the model predicts that this site has
the highest relative affinity for CstF. We used two ap- We next asked whether the increased binding of CstF
to the mm poly(A) site was functionally significant, byproaches to test this. In the first, gel-shift assays were
performed using a purified glutathione S-transferase– comparing the 39 cleavage efficiencies of the mm and
ms RNAs in reconstituted in vitro processing reactions.CstF-64 RBD fusion protein (GST–RBD; contains resi-
dues 1–108 of hCstF-64) and RNAs containing the mm Although previous in vitro assays employing B cell nu-
clear extracts (Yan et al., 1995) have suggested that theor ms poly(A) site. The results (Figure 6A) indicate that
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change in the concentration of the general polyadenyla-
tion factor CstF-64. Although it has been proposed pre-
viously that modulating the concentration or activity of
essential RNA processing factors might provide a means
of regulating specific RNA processing events, ours is
the first study to provide direct experimental support
for this idea. Below, we discuss this form of regulation,
not only as it applies during differentiation of B cells,
but also how it may reflect a more general means of
gene control.
The data we have presented allow us to propose a
detailed model for control of the mm-to-ms mRNA
switch. The first part of the model concerns the status
of CstF (Figure 8A). In B cells, our data suggest that
CstF is the limiting factor for 39 end formation, owing to
the reduced accumulation of CstF-64. (We have not
been able to measure the levels of CstF-50, owing to
lack of an antibody able to detect the mouse or chicken
protein, and it is thus an assumption that its levels do not
change. However, because increasing the concentration
Figure 5. Overexpression of CstF-64 Enhances CstF Complex For- of CstF-64 is sufficient to induce the processing switch,
mation CstF-50 cannot be functionally limiting.) Increasing the
(A) Whole-cell lysates (18 mg) derived from the pApuro vector (vector, concentration of CstF-64 thus allows a corresponding
number 6, lanes 1 and 3) and pApuro-flu64K (flu64K, number 23, increase in CstF accumulation, until the point at which
lanes 2 and 4)–transfected cell lines were analyzed by Western
one of the other subunits becomes limiting. How doesblotting using anti-77K (lanes 1 and 2) or anti-64K (lanes 3 and 4)
theconcentration of CstF influence theselection of alter-antibodies. Positions of CstF-77K and -64 are indicated by arrow-
native poly(A) sites? Our data support the simple modelheads on the right.
(B) CstF complexes were immunoaffinity-purified from extracts of illustrated in Figure 8B. Under conditions in which CstF
pApuro vector (vector, number 6, lanes 1 and 3) and pApuro-flu64K is limiting (i.e., B cells), the weaker ms poly(A) site is not
(flu64K, number 23, lanes 2 and 4)–transfected cells. CstF subunits recognized efficiently because of its lower affinity for
eluted from the anti-64K antibody–protein G Sepharose conjugates CstF and is removed from the pre-mRNA by the Cm4–M1
were detected by Western blotting.
splice reaction; the site with a higher affinity (i.e., mm)
is used effectively. When the concentration of CstF in-
mm poly(A) site is stronger than the ms site, we wished creases (i.e., in plasma cells), this results in a significant
to determine whether this difference could be observed increase in utilization of the ms poly(A) site, out-compet-
in reactions reconstituted with only the general polyade- ing the Cm4–M1 splicing event or mm polyadenylation
nylation factors, including CstF. We therefore performed or both. Although our in vitro data indicates that both the
in vitro processing reactions with the pre-mRNAs em- ms and mm poly(A) sites in isolation respond to increased
ployed in the gel-shift assays, purified CstF, and prepa- levels of CstF, the increase in use of the ms poly(A)
rations of the other essential 39 processing factors, site is the critical event in regulating m gene pre-mRNA
CPSF, CFI, CFII, and PAP. Reaction mixtures contained processing. Since the ms poly(A) site is transcribed first,
increasing concentrations of CstF and saturating con- a significant fraction of the sites may be recognized or
centrations of the other factors. Only the first step of cleaved or both before the 39 M1 splice junction and
the reaction (RNA cleavage) was assayed (Figure 7A), strong mm poly(A) site have been transcribed. Indeed,
and results were quantitated by calculating the amount enhanced polyadenylation efficiency could increase ter-
of upstream cleavage products relative to the total mination prior to transcription of the mm site (e.g., Guise
amount of pre-mRNA added to reaction mixtures (Figure et al., 1988). Note that the only assumption of our model
7B). These results show that the mm pre-mRNA was is that CstF levels in natural B cells are indeed limiting,
cleaved 2–3-fold more efficiently than the ms pre-mRNA so that increasing CstF-64 would in fact enhance poly-
at all CstF concentrations tested. Taken together, our adenylation efficiency. All of our data are consistent with
data suggest that the mm poly(A) site is intrinsically this supposition.
stronger than the ms site and that this difference results The above model is remarkably similar to one pro-
at least in part from the different affinities of the two posed over a decade ago by Blattner and Tucker (1984).
sites for CstF. At that time, little was known about the signals required
for polyadenylation and nothing at all about the polyade-
Discussion nylation machinery. Their model was based entirely on
the known m gene and mRNA structures. The authors
The switch from synthesis of membrane-bound to se- proposed the existence of an enzyme that cleaved
creted form m heavy chain mRNA during B cell differenti- mRNA precursors to generate 39 ends, which they
ation has been a paradigm for regulation at the level of dubbed “endase.” They hypothesized that endase was
mRNA processing for many years. The data presented present in limiting amounts in B cells and that the ms
here provide evidence that regulation occurs by control poly(A) site was used less frequently than the mm site
owing to a low affinity of endase for the ms site. Theof 39 end formation and that this is brought about by a
Regulation of IgM Pre-mRNA Processing
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Figure 6. CstF Has Higher Affinity for the mm
poly(A) site Relative to the ms poly(A) Site
(A) Gel retardation assays with GST–CstF-64
RBD fusion protein. No protein (lanes 1 and
9), 24 mM GST (lanes 2 and 10), or 24 (lanes
3 and 11), 12 (lanes 4 and 12), 6 (lanes 5 and
13), 3 (lanes 6 and 14), 1.5 (lanes 7 and 15),
or 0.75 mM (lanes 8 and 16) GST–RBD was
incubated with 1.5 nM mm (lanes 1–8) or ms
(lanes 9–16) pre-mRNA, and RNA–protein
complexes and free RNA were separated on
a nondenaturing polyacrylamide gel.
(B) Gel retardation assays with purified CstF.
250 (lanes 2 and 8), 125 (lanes 3 and 9), 62.5
(lanes 4 and 10), 31.3 (lanes 5 and 11), 15.6
(lanes 6 and 12), or 0ng (lanes 1 and 7) of
purified CstF was incubated with 1.5 nM mm
(lanes 1–6) or ms (lanes 7–12) pre-mRNA, and
RNA–protein complex and free RNA were
separated on a nondenaturing polyacryl-
amide gel.
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Figure 7. mm Pre-mRNA Is Processed In
Vitro More Efficiently Than ms Pre-mRNA
(A) In vitro cleavage reactions. mm (lanes 2–8)
or ms (lanes 10–16) pre-mRNA was incubated
in reaction mixtures containing CPSF, CFI,
CFII, and PAP in the presence of 0 (lanes 2
and 10), 0.31 (lanes 3 and 11), 0.63 (lanes 4
and 12), 1.25 (lanes 5 and 13), 2.5 (lanes 6 and
14), 5 (lanes 7 and 15), or 10 ng (lanes 8 and
16) of purified CstF. The mm (lane 1) and ms
(lane 9) pre-mRNAs (Pre) and the reaction
products (lanes 2–8 and10–16) were fraction-
ated as in Figure 4A. Positions of the up-
stream and downstream cleavage products
are indicated. A set of two upstream cleavage
products were detected after cleavage of ms
pre-mRNA (Yan et al., 1995).
(B) Quantitation of cleavage efficiencies. The
amounts of upstream cleavage products
were quantitated from the polyacrylamide gel
shown in (A).
concentration of endase was proposed to increase dur- et al., 1994) and are essential for viability (Minvielle-
Sebastia et al., 1991). These observations beg the ques-ing B cell differentiation, resulting in preferential utiliza-
tion of the ms site in plasma cells. The key features of tion of whether it is reasonable that cells regulate the
expression of specific genes by modulating the levelsthis model and the one suggested by our data are thus
almost identical. Perhaps the most significant difference of an essential general polyadenylation factor. A pair of
considerations, not mutually exclusive, argue for theis that the polyadenylation machinery is much more
complex than that envisioned by Blattner and Tucker, feasibility of this mechanism. First, our datashowed, and
theabove model requires, that CstF levels are reduced inand one subunit, CstF-64, plays the regulatory role sug-
gested for the hypothetical endase. resting B cells. As the name implies, these cells are not
actively dividing and thus may be able to tolerate lowerCstF has been shown to be required for efficient poly-
adenylation in vitro of all pre-mRNAs tested (reviewed levels of CstF than rapidly growing cells. Second, analy-
sis of nuclear pre-mRNAs has frequently revealed accu-by Keller, 1995; Manley, 1995). The gene encoding the
CstF-77 homolog in Drosophila, su(f), is essential, and mulation of polyadenylated RNAs that are incompletely
spliced (e.g., Nevins and Darnell, 1978; Manley et al.,null mutations result in cell-autonomous lethality (Mit-
chelson et al., 1993). The probable yeast homologs of 1982). Electron microscopic studies of nuclear spreads
are also consistent with rapid 39 end formation (BeyerCstF-77 and CstF-64, RNA14 and RNA15, are also re-
quired for polyadenylation in vitro (Minvielle-Sebastia and Osheim, 1988). Thus, it could be that polyadenyla-
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Figure 8. Regulation of m Gene Expression by CstF-64
(A) CstF-64 is limiting for CstF complex formation in B cells. Because expression of CstF-64 is specifically reduced in B cells, a considerable
fraction of the CstF complexes may exist as functionally inactive 77 kDa–50 kDa dimers, which may accumulate or be degraded (top). At the
final stage of differentiation (plasma cells), CstF-64 expression is increased, resulting in a significant increase in formation of functionally
active heterotrimeric CstF (bottom).
(B) Enhanced CstF accumulation switches m gene expression from mm to ms mRNA. In B cells (top), with limiting amounts of functional CstF
(hatched circles), Cm4–M1 splicing competes effectively with the weaker ms poly(A) site, and the mm poly(A) site, which binds CstF more
strongly, is efficiently used. In plasma cells (bottom), with higher amounts of CstF, the upstream ms poly(A) site is primarily used. CPSF, which
forms a stable complex with CstF, is shown by dotted circles, and the mm and ms poly(A) sites are indicated by arrows. The thickness of the
arrows reflects the relative utilization of the two poly(A) sites.
tion is not the rate-limiting step in synthesis of many in our experiments. One possibility is that B cells and
memory B cells employ distinct mechanisms to regulatemRNAs, and reductions in the concentration of a factor
such as CstF, while slowing the rate of polyadenylation, CstF activity. However, an alternative explanation re-
flects possible differences between transformed cellmight have relatively small effects on the overall kinetics
of mRNA synthesis. Indeed, significant effects may be lines and primary cells. Lymphomas are tumor-derived
cells selected for rapid growth and which have beenlimited to transcripts, such as m pre-mRNA, with poly(A)
sites in competition with other poly(A) sites or splice maintained for long periods in culture. Given that CstF-
64 plays an essential role in an important cellular pro-sites or both.
Our experiments have provided support for the idea cess, it is not unreasonable that selection might eventu-
ally occur in lymphoma cell lines for derepressed levelsthat regulation of CstF-64 is critical for modulating the
mm-to-ms RNA processing switch. But they do not rule of CstF-64. Indeed, this possibility is reflected in the
secreted–membrane-form mRNA ratios found in manyout the possibility that additional factors may contribute
to this process, and studies employing B lymphoma and lymphomas. For example, the lymphoma cell lines em-
ployed by Edwalds-Gilbert and Milcarek (1995) had ra-plasmacytoma cell lines have provided some support
for this idea. Yan et al. (1995) identified an activity in tios of 2, indicating that these cells have lost a fraction
of the regulation observed in vivo. However, tumor cellextracts of B lymphoma cells that could destabilize a
CPSF–CstF-ms pre-mRNA complex, which may contrib- lines have been used for many years to study Ig mRNA
processing, with B cell lines nearly always expressingute to reduced usage of the ms site in B cells. Edwalds-
Gilbert and Milcarek (1995) observed reduced ultraviolet lower ms–mm ratios than plasma cell lines. Thus, while
cell lines might not reproduce completely the regulationcross-linking of CstF-64 to poly(A) sites in nuclear ex-
tracts prepared from memory B cell lymphomas, com- observed with natural B cells, they may allow identifica-
tion of additional factors that can contribute to thepared with extracts from plasmacytomas. However,
Western blots of the extracts revealed comparable lev- change in ms–mm expression.
The data presented here have provided evidence thatels of CstF-64 in all cell lines, arguing that a factor dis-
tinct from CstF-64 was responsible for the differential modulating the levels of an essential pre-mRNA pro-
cessing factor can be a significant mechanism of genecross-linking. These findings appear to conflict with the
reduction in CstF-64 in mouse primary B cells observed control. We suspect that this will be a not uncommon
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medium supplemented with 10% fetal bovine serum and1% chickenmethod for regulating alternative pre-mRNA processing.
serum. DT40 cells (107) were transfected by electroporation with 30For example, it was proposed some time ago that
mg of linearized pApuro or pApuro-flu64K (Buerstedde and Takeda,changes in the concentration of the splicing factor ASF/
1991). Drug selection was begun 24 hr after transfection by growing
SF2 might be able to modulate alternative splicing in medium containing 0.5 mg/ml of puromycin. Expression of flu–
events in vivo (Ge and Manley, 1990; Krainer et al., 1990). CstF-64 was analyzed by Western blotting using an anti-flu antibody
(hybridoma 12CA5; Field et al., 1988).ASF/SF2 is a member of the SR protein family of splicing
factors, which are required for splicing in vitro. The con-
Antibody Preparation and Western Blot Analysiscentration of these proteins can vary in different tissues
To prepare anti–CstF-64 polyclonal antibodies, a fragment con-(e.g., Zahler et al., 1993), and overexpression of individ-
sisting of the N-terminal 261 residues of hCstF-64 was expressed
ual SR proteins in transient cotransfection assays can in BL21 cells transformed with the plasmid pET-64N, purified from
modulate alternative splicing (Ca´ceres et al., 1994; Wang a 10% SDS–polyacrylamide gel by electroelution (Harlow and Lane,
and Manley, 1995). Thus, varying the concentration of 1988), dialyzed against phosphate-buffered saline, and used to im-
munize rabbits (Pocono Rabbit Farm). To obtain antibodies againstthese proteins will likely be found to be a mechanism
cCstF-64, the anti-human antibodies were affinity-purified using afor controlling splice site selection in vivo. With respect
fragment consisting of residues 1–118 of cCstF-64. Cultured cellsto polyadenylation, it is likely that additional examples
were harvested and washed twice in phosphate-buffered saline.
of regulation employing mechanisms similar to those Cell pellets were resuspended in ice-cold dialysis buffer containing
described here will be uncovered. This may involve fac- 20 mM HEPES–NaOH (pH 7.9), 20% glycerol, 100 mM NaCl, 0.2
tors other than CstF-64, with CstF-77/su(f) being an ex- mM EDTA, 0.5 mM dithiothreitol, and 0.5 mM phenylmethylsulfonyl
fluoride, and sonicated. After determination of protein concentra-cellent candidate. Mutations in su(f) are most often de-
tions, whole-cell lysates were mixed with equal volumes of 2 3 SDStected as modifiers of phenotypes arising from insertion
protein gel loading buffer, fractionated on 10% SDS–polyacrylamideof transposable elements in the introns of target genes
gels, and transferred to nitrocellulose membranes. Proteins were
(reviewed by O’Hare, 1995), which likely result from detected with the indicated antibodies, and the antigen–antibody
changes in the efficiency of polyadenylation in the long complexes were detectedby chemiluminescence (ECL, Amersham).
terminal repeat of the transposable element relative to
Analysis of Endogenous m Gene Expressionthe natural poly(A) signal. Thus, subtle changes in su(f)
DT40 cells stably transfected with the pApuro vector or pApuro-are able to influence poly(A) site selection, a property
flu64 were inoculated at 2 3 104 and 4 3 104 cells/ml. Cells werethat makes CstF-77/su(f) a logical candidate for regula-
harvested after 48 hr, washed as above, and total cellular RNA was
tion. An intriguing situation suggestive of regulation by isolated (Chomczynski and Sacchi, 1987). To prepare a probe for
modulation of poly(A) factor levels is control of CREM S1 analysis, cDNAs were first synthesized using (dT)20 as a primer
gene expression during spermatogenesis (Foulkes et and poly(A)1 RNA isolated from DT40 cells as a template. A ms cDNA
fragment was then amplified by polymerase chain reaction andal., 1993). This developmental switch involves a 59 shift
cloned into pBluescript to give pCh-ms. An NcoI–SacI fragment wasin utilization of poly(A) sites in the 39 UTR of the CREM
isolated from pCh-ms and 39-end–labeled with a32P-dCTP. RNA (7.5pre-mRNA, which results in synthesis of a shorter, more
mg) was hybridized with 5 3 104 cpm of the probe in 15 ml of hybrid-stable mRNA. This mode of regulation is very similar to
ization buffer at 378C for 16 hr. The hybridization mixtures were
that observed in the m gene, except that splicing is treated with 150 ml of S1 nuclease buffer containing 1,500 U/ml of
not involved. While future studies will be required to S1 nuclease (Sigma) at 138C for 1.5 hr, and the protected DNA
fragments were fractionated on an 8.3 M urea–5% polyacrylamidedetermine whether this, or other, regulated switches in
gel. Gels were quantitated by Phosphorimager analysis (MolecularRNA processing involve changes in the concentration
Dynamics).or activity of a component of the basal processing ma-
For quantitation of secreted IgM H-chain, DT40 cells were washedchinery, our data has provided evidence for the impor-
and passed at least twice in culture medium lacking chicken serum
tance of this mechanism during B cell differentiation. and then inoculated into the same medium. Later (2 days), cells were
centrifuged twice at 7,000 rpm in a microfuge, and 15 ml aliquots of
each culture supernatant were loaded on a 10% SDS–poly-Experimental Procedures
acrylamide gel. Chicken IgM H-chain was detected as above using
horseradish peroxidase–conjugated anti-chicken IgM H-chain anti-Isolation of Mouse Primary B Cells
body (Bethyl Laboratories).Splenocytes from 6–8-week-old C3Hx C57/BL6 littermates were iso-
lated and treated with an anti-thy.1 monoclonal antibody derived
from hybridoma 13-4.6 (American Type Culture Collection), an anti- Isolation of CstF Complexes
L3T4 monoclonal antibody derived from hybridoma RL-172/4 To isolate CstF complexes from stably transfected DT40 cells, an
(Ceredig et al., 1985), and baby rabbit complement (Pel Freez Inc.) anti–CstF-64 monoclonal antibody (a64K; Takagaki et al., 1990) was
to remove T cells. High density resting B cells isolated from the conjugated to protein G Sepharose as described (Takagaki and
60%–70% interface of Percoll buoyant density gradients (DeBene- Manley, 1994). Whole-cell extractswere prepared as reported (Taka-
dette and Snow, 1991) were washed and diluted to 2–5 3 106 cells/ gaki and Manley, 1994) with slight modifications. In brief, cells were
ml in RPMI-1640 medium supplemented with 50 mM 2-ME, 2 mM harvested at approximately 5 3 105 cells/ml and washed with phos-
glutamine, and 10% fetal bovine serum. Cells were harvested imme- phate-buffered saline. Cells (1.5 3 107) were resuspended in 1 ml
diately or cultured for 72 hr in the same medium containing 50 mg/ of ice-cold lysis buffer containing 300 mM NaCl. After removing cell
ml of LPS. debris and adding glycerol, extracts were passed through a64K–
PGS conjugates three times over 1 hr. After extensive washing, the
resins were resuspended in 170 ml of SDS gel-loading buffer andCell Growth and Transformation
equal volumes analyzed by Western blotting.Chicken CstF cDNAs were isolated from a chicken spleen cDNA
library in the lgt 11 vector using a probe derived from pZ64-18
(Takagaki et al., 1992). To differentiate cCstF-64 encoded by Gel Retardation Assays and In Vitro Cleavage Reactions
To prepare RNAsubstrates, fragments derived from pSV5ms–m con-transfected DNA from the endogenous protein, an influenza HA (flu)-
epitope was fused to the N-terminus of the protein. The flu–CstF- taining the mm and ms poly(A) sites (Peterson and Perry, 1986) were
first subcloned into pGEM3. The m gene–derived sequences were64 encoding fragment was then inserted into the pApuro vector.
DT40 cells (Buerstedde et al., 1990) were maintained in RPMI-1640 terminated at the same distance from the mm and ms poly(A) sites
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(87 nt) by polymerase chain reaction. The polymerase chain reaction and Hood, L. (1980). Two mRNAs can be produced from a single
immunoglobulin m gene by alternative RNA processing pathways.products were inserted into pGEM3, and capped pre-mRNAs were
transcribed from the linearized plasmids by SP6 RNA polymerase Cell 20, 313–319.
and gel-purified. For the gel retardation assays in Figure 6A, GST or Edwalds-Gilbert, G., and Milcarek, C. (1995). Regulation of poly(A)
GST–RBD fusion protein was incubated with pre-mRNA in reaction site use during mouse B-cell development involves a change in the
mixtures (12.5 ml) containing 8 mM HEPES–NaOH (pH 7.9), 8% binding of a general polyadenylation factor in a B-cell stage-specific
(v/v) glycerol, 40 mM NaCl, 2 mM EDTA, 0.2 mM dithiothreitol, 0.2 manner. Mol. Cell. Biol. 15, 6420–6429.
mM phenylmethylsulfonyl fluoride, 1 mM ATP, 20 mM CP, and 40
Field, J., Nikawa, J.-I., Broek, D., MacDonald, B., Rodgers, L., Wil-
mg/ml of Escherichia coli RNA at 308C for 10 min. RNA–protein
son, I.A., Lerner, R.A., and Wigler, M. (1988). Purification of acomplexes were resolved on a 5% nondenaturing polyacrylamide
RAS-responsive adenylyl cyclase complex from Saccharomycesgel containing 2.5% glycerol and 0.5 3 TGE by electrophoresis at
cerevisiae by use of an epitope addition method. Mol. Cell. Biol. 8,1.0 W in the cold room. For the assays shown in Figure 6B, purified
2159–2165.CstF (MonoS, purity greater than 90%; Takagaki et al., 1990) was
Foulkes, N.S., Schlotter, F., Pevet, P., and Sassone-Corsi, P. (1993).incubated with RNAs in reaction mixtures (12.5 ml) containing the
Pituitary hormone FSH directs the CREM functional switch duringsame buffer as above, except with 20 mM (NH4)2SO4 instead of NaCl.
spermatogenesis. Nature 362, 264–267.After incubation with 5 mM heparin for 10 min, RNA–protein complex
and free RNA were separated on a 4% nondenaturing polyacryl- Ge, H., and Manley, J.L. (1990). A protein factor, ASF, controls cell-
amide gel. specific alternative splicing of SV40 early pre-mRNA in vitro. Cell
For in vitro 39 cleavage reactions, 2.5 nM of each pre-mRNA was 62, 25–34.
incubated with partially purified CPSF (1 ml, Mono Q), CFI and -II (2 Gilmartin, G.M., and Nevins, J.R. (1991). Molecular analyses of two
ml, Mono Q), PAP (1 ml, Mono S), and the indicated amounts of poly(A) site-processing factors that determine the recognition and
MonoS purified CstF (Takagaki et al., 1989, 1990) in reaction mix- efficiency of cleavage of the pre-mRNA. Mol. Cell. Biol. 11, 2432–
tures (12.5 ml) containing the same buffer used for the CstF gel 2438.
retardation assays plus 2.5% (w/v) polyvinyl alcohol at 308C for 75
Guise, J.W., Lim, P.L., Yuan, D., and Tucker, P.W. (1988). Alternativemin. RNAs were purified and fractionated on an 8.3 M urea–5%
expression of secreted and membrane forms of immunoglobulinpolyacrylamide gel. Gels were quantitated by Phosphorimager, tak-
m-chain is regulated by transcriptional termination in stable plas-ing into account the numbers of 32P-labeled G residues.
macytoma transfectants. J. Immunol. 140, 3988–3994.
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